Human T lymphotropic virus (HTLV) 1/2 antibodies, qual-13539

Test info

  
Human T lymphotropic virus (HTLV) 1/2 antibodies, qual
  
13539
  
LAB13539
  
HTLV
  
HTLV-I/HTLV-II
HTLV I/II antibodies qual
  

Positive screening results will automatically reflex to confirmation testing

  

Screen patients for infection with human T-lymphotropic virus and, if positive, confirm infection with either HTLV-1 or HTLV-2

Specimen

  
Serum
  

Gold serum separator (SST) tube

  
2.0 mL
  
1.5 mL
  

Immediately following collection, mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  4. Freeze
  

Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp)

  
EDTA plasma
  

Red serum vial/tube, 5 mL

Lavender (EDTA), 4mL

  

Lavender:

Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

  

Red:

  1. Spin within two (2) hours of sample collection
  2. Transfer serum to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as serum
  3. Freeze

Lavender:

  1. Spin within two (2) hours of sample collection
  2. Transfer plasma to a Screw-cap polypropylene frozen transport vial/tube - 4mL (LabCorp), labelled as EDTA plasma
  3. Freeze
  

Frozen (preferred) - 6 months

Refrigerated - 14 days

Ambient - 7 days

Freeze/thaw cycles - stable x6

  
  • Gross bacterial contamination
  • Hemolysis
  • Lipemia

Performance

  
Viracor Eurofins via LabCorp (164277): R-LC
  
1 - 4 days
  

Chemiluminescent microparticle immunoassay (CMIA); line blot (immunoblot)

Clinical and Interpretive info

  

Negative

Billing

  
86790
  
Result 29901-6

Tracking

  
04/08/2019
  
07/01/2024
  
01/03/2024